logo
logo

Antheia Announces New Financing And Plans To Construct Pilot Plant Facility For Biomanufacturing

Jun 22, 2022•about 3 years ago
Menlo Park

Description

Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced $40 million in venture debt financing from Oxford Finance LLC and Silicon Valley Bank, alongside plans to construct a new pilot scale biomanufacturing facility. The financing will support Antheia's expansion with a 14,700 square-foot pilot plant located next to Antheia's headquarters in Menlo Park, CA. The new pilot plant will enable the company to significantly improve efficiency and support the scale up of its growing portfolio of products.

Company Information

Company

Antheia

Location

Menlo Park, California, United States

About

Antheia is unlocking the medicinal power of nature with synthetic biology. Through a novel whole-cell engineering approach to reconstruct complex molecules in yeast, Antheia's platform enables the discovery and manufacturing of plant-inspired drugs of unprecedented complexity and diversity. Antheia's team of scientists and technologists is headquartered in Menlo Park, California. For more information, visit www.antheia.bio. CONTACT: Mission North for Antheia, antheia@missionnorth.com